Get the Stockscreener App
7.93
3.39%
0.26
After Hours:
7.87
-0.06
-0.76%
Lifestance Health Group Inc stock is traded at $7.93, with a volume of 8.69M.
It is up +3.39% in the last 24 hours and up +23.91% over the past month.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
See More
Previous Close:
$7.67
Open:
$7.66
24h Volume:
8.69M
Relative Volume:
2.28
Market Cap:
$3.08B
Revenue:
$1.42B
Net Income/Loss:
$9.66M
P/E Ratio:
317.20
EPS:
0.025
Net Cash Flow:
$110.03M
1W Performance:
+8.04%
1M Performance:
+23.91%
6M Performance:
+23.14%
1Y Performance:
+35.56%
1-Day Range:
$7.615
$7.945
1-Week Range:
$7.31
$8.89
52-Week Range:
$3.74
$8.89
Lifestance Health Group Inc Stock (LFST) Company Profile
Name
Lifestance Health Group Inc
Sector
Industry
Phone
602-767-2100
Address
4800 N. SCOTTSDALE ROAD, SCOTTSDALE
Compare LFST vs HCA, THC, DVA, FMS, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LFST
Lifestance Health Group Inc
|
7.93 | 2.97B | 1.42B | 9.66M | 110.03M | 0.025 |
HCA
Hca Healthcare Inc
|
429.69 | 94.59B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
195.88 | 16.51B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
200.54 | 12.77B | 13.64B | 1.05B | 1.31B | 9.555 |
FMS
Fresenius Medical Care Ag Adr
|
22.24 | 11.69B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
108.08 | 10.40B | 6.07B | 793.80M | 464.40M | 5.9914 |
Lifestance Health Group Inc Stock (LFST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Jul-25-25 | Initiated | BTIG Research | Buy |
| May-27-25 | Upgrade | UBS | Neutral → Buy |
| Apr-08-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-03-25 | Initiated | Canaccord Genuity | Buy |
| Dec-16-24 | Upgrade | Goldman | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Underweight |
| May-15-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-06-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-07-22 | Resumed | Jefferies | Buy |
| Mar-17-22 | Downgrade | UBS | Buy → Neutral |
| Nov-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Aug-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-06-21 | Initiated | Goldman | Neutral |
| Jul-06-21 | Initiated | JP Morgan | Overweight |
| Jul-06-21 | Initiated | Jefferies | Buy |
| Jul-06-21 | Initiated | Morgan Stanley | Overweight |
| Jul-06-21 | Initiated | William Blair | Outperform |
View All
Lifestance Health Group Inc Stock (LFST) Latest News
[8-K] LifeStance Health Group, Inc. Reports Material Event - Stock Titan
LifeStance Health Group (LFST) Stock Trades Down, Here Is Why - Yahoo Finance
LifeStance Health Group prices secondary offering at $8.15 per share - MSN
LifeStance Deadline Alert - TMX Newsfile
LFST Q1 Deep Dive: Technology and Clinician Productivity Drive Outperformance and Guidance Increase - Yahoo Finance
LifeStance Health director Robert Bessler sells $641,250 in shares By Investing.com - Investing.com Australia
LifeStance Health director Robert Bessler sells $641,250 in shares - Investing.com
75K LifeStance (NASDAQ: LFST) shares sold by director-linked entities - Stock Titan
LifeStance Health Group, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:LFST) 2026-05-10 - Seeking Alpha
LFST Drops As LifeStance Secondary Offering Hits Market - timothysykes.com
LifeStance Health Stock Slides After $8.15 Secondary Pricing - timothysykes.com
Summit holds 29.2M LifeStance shares (NASDAQ: LFST) in Schedule 13G/A - Stock Titan
[424B7] LifeStance Health Group, Inc. Prospectus Filed Pursuant to Rule 424(b)(7) - Stock Titan
LifeStance Health LFST Slides As 35M-Share Secondary Hits Market - StocksToTrade
LFST Stock Slips As 35M-Share Secondary Tests Market Demand - timothysykes.com
LFST Stock Slips As 35M-Share Secondary Tests Demand - StocksToTrade
35M-share resale by LifeStance (NASDAQ: LFST) with 6M-share repurchase - Stock Titan
LFST Stock Pressured As 35M-Share Secondary Hits Market - timothysykes.com
LifeStance Health stock tumbles on secondary offering pricing By Investing.com - Investing.com Australia
LifeStance Health stock tumbles on secondary offering pricing - Investing.com
LifeStance Q1 2026 presentation: 21% revenue growth, guidance raised By Investing.com - Investing.com Canada
Lifestance Health Group stock hits 52-week high at $8.11 By Investing.com - Investing.com Canada
Why Lifestance Health Group Shares Are Sliding - TipRanks
MSN Money - MSN
Latest LFST NewsLifeStance Health Announces Second Quarter ... - Stock Titan
LifeStance Health Group (LFST) Earnings Date and Reports 2026 $LFST - MarketBeat
LifeStance Health Group Q1 Earnings Call Highlights - Yahoo Finance
LifeStance Agreed to Purchase 6M Shrs From Underwriter of Offering >LFST - Moomoo
LifeStance Health prices secondary offering at $8.15 per share - Investing.com
LifeStance (LFST) Hits 2-Year High as Q1 Profits Soar 1,900% - Insider Monkey
LifeStance Health Lifts Outlook on Profitable Q1 - TipRanks
LifeStance Health prices secondary offering at $8.15 per share By Investing.com - Investing.com South Africa
LifeStance Health Group Announces Pricing of Secondary Public Offering - The Manila Times
Why LifeStance Health Group zoomed 20% higher today - MSN
Lifestance Health Group announces pricing of secondary public offering - marketscreener.com
Lifestance Health Group Announces Pricing Of Secondary Public Offering - TradingView
LifeStance shareholders launch 35 million-share secondary offering - MSN
LifeStance Health Group Q1 2026 Earnings Call Transcript - MarketBeat
LifeStance stockholders plan 35M share offering - Investing.com UK
Why LifeStance Health Group Zoomed 20% Higher Today - The Motley Fool
LifeStance Health Group, Inc. Stock 12‑Month Price Target Raised to $9.94, Implies 35% Upside - TradingView
LifeStance Health Group (LFST) Eps Diluted (TTM) - Zacks Investment Research
LifeStance stockholders plan 35M share offering By Investing.com - Investing.com Australia
LifeStance Health Group Announces Launch of Secondary Public Offering - The Manila Times
LifeStance Health Group, Inc. Announces Stockholder Offering of 35 Million Shares and Concurrent Repurchase of 6 Million Shares - Quiver Quantitative
LifeStance Health Group, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
LifeStance holders offer 35M shares; company plans 6M buyback - Stock Titan
75,000-share Form 144 filing by LifeStance Health (NASDAQ: LFST) - Stock Titan
LifeStance Health Group, Inc. 1Q 2026: Revenue $403.5M, EPS $0.04— 10-Q Summary - TradingView
LifeStance (NASDAQ: LFST) posts Q1 2026 revenue of $403,476 - Stock Titan
LifeStance CEO Says M&A Tuck-In Deals, De Novos Are Back on the Table - Behavioral Health Business
Lifestance Health Group Inc Stock (LFST) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.28%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):